PL358032A1 - Nowe zastosowanie 22R-(11, 16 )-16,17-[butylideno-bis(oksy)]-11,21-dihydroksypregna-1,4-dieno-3,20-dionu - Google Patents

Nowe zastosowanie 22R-(11, 16 )-16,17-[butylideno-bis(oksy)]-11,21-dihydroksypregna-1,4-dieno-3,20-dionu

Info

Publication number
PL358032A1
PL358032A1 PL02358032A PL35803202A PL358032A1 PL 358032 A1 PL358032 A1 PL 358032A1 PL 02358032 A PL02358032 A PL 02358032A PL 35803202 A PL35803202 A PL 35803202A PL 358032 A1 PL358032 A1 PL 358032A1
Authority
PL
Poland
Prior art keywords
dihydroxypregna
butylidene
dione
diene
oxy
Prior art date
Application number
PL02358032A
Other languages
English (en)
Other versions
PL207060B1 (pl
Inventor
Beata Rostkowska-Nadolska
Stanisław Szymaniec
Wojciech Fortuna
Wiesław Szelejewski
Teresa Uszycka-Horawa
Hanna Zakrzewska-Karniewicz
Original Assignee
Instytut Farmaceutyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Farmaceutyczny filed Critical Instytut Farmaceutyczny
Priority to PL358032A priority Critical patent/PL207060B1/pl
Publication of PL358032A1 publication Critical patent/PL358032A1/pl
Publication of PL207060B1 publication Critical patent/PL207060B1/pl

Links

PL358032A 2002-12-30 2002-12-30 Zastosowanie 22R-(11 β,16α)-16,17-[butylideno-bis(oksy)]-11,21-dihydroksypregna- -1,4-dieno-3,20-dionu i środek farmaceutyczny PL207060B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL358032A PL207060B1 (pl) 2002-12-30 2002-12-30 Zastosowanie 22R-(11 β,16α)-16,17-[butylideno-bis(oksy)]-11,21-dihydroksypregna- -1,4-dieno-3,20-dionu i środek farmaceutyczny

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL358032A PL207060B1 (pl) 2002-12-30 2002-12-30 Zastosowanie 22R-(11 β,16α)-16,17-[butylideno-bis(oksy)]-11,21-dihydroksypregna- -1,4-dieno-3,20-dionu i środek farmaceutyczny

Publications (2)

Publication Number Publication Date
PL358032A1 true PL358032A1 (pl) 2004-07-12
PL207060B1 PL207060B1 (pl) 2010-10-29

Family

ID=32845081

Family Applications (1)

Application Number Title Priority Date Filing Date
PL358032A PL207060B1 (pl) 2002-12-30 2002-12-30 Zastosowanie 22R-(11 β,16α)-16,17-[butylideno-bis(oksy)]-11,21-dihydroksypregna- -1,4-dieno-3,20-dionu i środek farmaceutyczny

Country Status (1)

Country Link
PL (1) PL207060B1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3182467T3 (pl) 2015-12-15 2020-06-15 Ml System Spółka Akcyjna Moduł fotowoltaiczny lameli żaluzji

Also Published As

Publication number Publication date
PL207060B1 (pl) 2010-10-29

Similar Documents

Publication Publication Date Title
AU2003245660A1 (en) Task based polymorphic graphical program function nodes
AU2009201956A2 (en) Pregnane steroids for use in the treatment of CNS disorders
IS7425A (is) Flúraðar 4-azasteróíð afleiður sem andrógen viðtakastillar
SI1602662T1 (sl) Postopek pridobivanja 17alfa-acetoksi-11beta-(4-N,N-dimetilaminofeli) -19-norpregna-4,9-dien-3,20-diona
AU2002353158A1 (en) Installation of evacuated tubular conduits
SG116499A1 (en) Dual-gate structure and method of fabricating integrated circuits having dual-gate structures.
AU2002361758A1 (en) Based, triple-well fully depleted soi structure, and various methods of making and operating same
AU2003304425A1 (en) Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same
AU2003233733A1 (en) Compositions for cancer therapy saponins or sapogenins
IL144916A0 (en) Immunomodulatory steroids, in particular the hemihydrate of 16-alpha-bromoepiandrosterone
AU2003237767A1 (en) Single wafer fabrication of integrated micro-fluidic system
WO2003082894A3 (en) C-17 spirolactonization and 6,7 oxidation of steroids
AU2003270680A1 (en) Tubular structures and methods for making the same
MXPA03004123A (es) Proceso para la produccion de 16, 17-[(ciclohexilmetilen) bis(oxy)]-11, 21-dihidroxi-pregna-1, 4-dien-3, 20-dion o su 21-isobutirat por trnasquetalisacion.
AU2003255364A1 (en) Isolated phase bus duct joint assembly
HU9201190D0 (en) Method for producing new pregna-1,4-diene-3,20-dione derivatives
DE60327946D1 (de) Angiogen-wirkende trisulfat steroide und deren verwendung
IL156807A0 (en) Androgenic 7-substituted 11-halogen steroids
AU2003276539A1 (en) Method for the selective rendering of body structures
WO2002026759A3 (de) 17α-FLUORALKYLSTEROIDE, VERFAHREN ZU DEREN HERSTELLUNG UND DIESE VERBINDUNGEN ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
IS7452A (is) Prógesterón viðtakastillar sem ekki eru steratengdir
ATE459636T1 (de) Stereospezifische reduktion von sapogen-3-onen
PL353602A1 (pl) Sposób otrzymywania androsta-1,4-dien-3,17-dionu
AU2002307602A1 (en) Preparation of glucocorticosteroids, 16, 17 acetals or ketals of pregnane derivatives
WO2003032924A3 (en) Novel tibolone formulations

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20131230